Unveiling Differences in Opioid Use Disorder Research: Dr. Daniel Sledge's Groundbreaking Study Reveals Urgent Need for Fair Clinical Trials

Dr. Daniel Sledge, Associate Professor of Health Administration and Policy, has recently published a significant article in the Journal of Substance Use and Addiction Treatment. His research delves into the dynamics of enrollment in clinical trials addressing Opioid Use Disorder (OUD) across different racial and ethnic groups.

Dr. Sledge's findings highlight variations in representation, with Native American participation falling below expected levels despite high mortality rates among this population. Conversely, Black Americans were enrolled at levels surpassing expectations, raising concerns about potential disparities. The study also noted mixed results regarding the representation of Asian American and Hispanic individuals, while White participants, although the majority, were represented at lower-than-expected levels based on demographics.

These insights underscore the importance of more inclusive practices in clinical trials. Dr. Sledge's work emphasizes the need to actively include Native American populations in OUD research efforts and calls for further investigation into enrollment disparities to improve the fairness and effectiveness of strategies aimed at combating Opioid Use Disorder.

You can read the full article at https://www.sciencedirect.com/science/article/pii/S294987592400050X

Dr. Daniel Sledge, Associate Professor of Health Administration and Policy, has recently published a significant article in the Journal of Substance Use and Addiction Treatment. His research delves into the dynamics of enrollment in clinical trials addressing Opioid Use Disorder (OUD) across different racial and ethnic groups.

Dr. Sledge's findings highlight variations in representation, with Native American participation falling below expected levels despite high mortality rates among this population. Conversely, Black Americans were enrolled at levels surpassing expectations, raising concerns about potential disparities. The study also noted mixed results regarding the representation of Asian American and Hispanic individuals, while White participants, although the majority, were represented at lower-than-expected levels based on demographics.

These insights underscore the importance of more inclusive practices in clinical trials. Dr. Sledge's work emphasizes the need to actively include Native American populations in OUD research efforts and calls for further investigation into enrollment disparities to improve the fairness and effectiveness of strategies aimed at combating Opioid Use Disorder. You can read the full article at https://www.sciencedirect.com/science/article/pii/S294987592400050X